CHIKUNGUNYA
Clinical trials for CHIKUNGUNYA explained in plain language.
Never miss a new study
Get alerted when new CHIKUNGUNYA trials appear
Sign up with your email to follow new studies for CHIKUNGUNYA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New chikungunya vaccine enters first human safety trial
⭐️ VACCINE ⭐️ Not yet recruitingThis early-stage trial tests a new vaccine called PepGNP-ChikV, made from tiny synthetic particles, to see if it is safe and triggers an immune response against chikungunya virus. Forty healthy adults aged 18 to 60 will receive two doses 42 days apart. The study focuses on safety…
Matched conditions: CHIKUNGUNYA
Phase: EARLY_PHASE1 • Sponsor: Gylden Pharma Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:24 UTC
-
One shot, two protections? new trial combines dengue and chikungunya vaccines
⭐️ VACCINE ⭐️ Not yet recruitingThis Phase 3 trial will test whether giving the dengue and chikungunya vaccines at the same time is as safe and effective as giving them separately. The study involves 900 healthy adults aged 18 to 59 who have never been exposed to either virus. Researchers will measure immune re…
Matched conditions: CHIKUNGUNYA
Phase: PHASE3 • Sponsor: Butantan Institute • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:11 UTC
-
Exercise program aims to restore strength after dengue and chikungunya
Symptom relief Not yet recruitingThis study tests whether a 20-session exercise program can improve muscle strength, reduce fatigue, and help with balance in people who had dengue or chikungunya in the last five years. Fifty-four adults will do supervised aerobic, strength, and breathing exercises twice a week. …
Matched conditions: CHIKUNGUNYA
Phase: NA • Sponsor: Universidade do Estado do Pará • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC